Table 1 Alternative treatment options
Options | Adjuvant imatinib treatment | Treatment after recurrence occurred | |
|---|---|---|---|
Recurrence | Progression | ||
Option 1 (baseline case) | No | Imatinib | BSC |
Option 2.1 Option 2.2 | 1Â year 3Â years | Imatinib (recurrence occurred after adjuvant therapy completed) | BSC |
BSC (recurrence occurred during adjuvant therapy) | Â | ||
Option 3.1 Option 3.2 | 1Â year 3Â years | Imatinib (recurrence occurred after adjuvant therapy completed) | Sunitinib |
Sunitinib (recurrence occurred during adjuvant therapy) | BSC | ||
Option 4 | No | Imatinib | Sunitinib |